Utility of CA 15-3 and CEA in monitoring breast cancer patients with bone metastases: Special emphasis on “spiking” phenomena

Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer.

Carlo Tondini, Daniel F. Hayes, Rebecca Gelman et al. · PubMed · 1988 · 159 citations

Medicine, Oncology, Pathology +17

Use of serum tumor markers in cancer diagnosis and management.

Susan E. Bates, Dan L. Longo · PubMed · 1987 · 113 citations

Medicine, Oncology, Cancer Screening +13

Value of CA 15:3 in the follow-up of breast cancer patients

D Pons-Anicet, B P Krebs, R Mira et al. · British Journal of Cancer · 1987 · 103 citations · Full text

Medicine, Oncology, Breast Oncology +4

Circulating CA 15-3 levels in the postsurgical follow-up of breast cancer patients and in non-malignant diseases

Rámón Colomer, Álvaro Ruibal, J Genollá et al. · Breast Cancer Research and Treatment · 1989 · 102 citations

Life Sciences, Oncology, Clinical Biochemistry +7

CA15-3: Its relationship to clinical stage and progression to metastatic disease in breast cancer

Michael J. Kerin, O. J. McAnena, Vincent O’Malley et al. · British journal of surgery · 1989 · 38 citations

Medicine, Oncology, Pathology +17